【About Our Speaker】Tsai-Yu Chen Ph.D.(Senior Scientist, Process Development, Lonza Houston Inc.)
Dr. Tsai-Yu Chen currently serves as a senior scientist in Process Development, Cell and Gene Technologies division at Lonza. He obtained his Ph.D. in Cancer Biology from The University of Texas MD Anderson Cancer Center / UT Health Graduate School of Biomedical Sciences in 2017. With a focus on mammalian and insect-cell based viral vector production systems, Dr. Chen possesses extensive expertise in various cell and gene therapy applications, such as Adeno-Associated Virus (AAV), Adenovirus, Lentivirus, Vesicular stomatitis virus, and Exosome Production. Transitioning from academic research to industry,
Dr. Chen emphasizes the importance of developing scalable processes from the academic setting to cGMP manufacturing as one of the key steps for the commercialization of cell and gene therapy products. In his current role, he leads a cross-functional team to develop cGMP-compliant processes for several prominent global biotech companies, enabling the production of cutting-edge cell and gene therapy products.
